These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23454647)

  • 1. Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach.
    Bhattacharya D; Lewis MJ; Lassmann B; Phan T; Knecht G; Bickel M; Yang OO
    J Virol Methods; 2013 Jun; 190(1-2):34-40. PubMed ID: 23454647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its application.
    Zeng Y; Li D; Wang W; Su M; Lin J; Chen H; Jiang L; Chen J; Yang B; Ou Q
    PLoS One; 2014; 9(2):e90029. PubMed ID: 24587198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of LigAmp assay for sensitive detection of drug-resistant hepatitis B virus minor variants in comparison with standard nucleotide sequencing.
    Ismail AM; Sachithanandham J; Eapen CE; Kannangai R; Abraham P
    Mol Diagn Ther; 2014 Dec; 18(6):655-63. PubMed ID: 25208639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid identification of YVDD mutants of hepatitis B virus using smart amplification process with competition probe.
    Yang J; Li J; Lou GQ; Wu LJ; Feng C; Wu NP
    Acta Virol; 2011; 55(4):295-302. PubMed ID: 22149494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.
    Mantovani N; Cicero M; Santana LC; Silveira C; do Carmo EP; Abrão PR; Diaz RS; Caseiro MM; Komninakis SV
    Virol J; 2013 Oct; 10():320. PubMed ID: 24165277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nanoscale Mutation-Sensitive On/Off Switch Based Assays for the Detection of Hepatitis B Virus Lamivudine-Resistant Mutations.
    Sun A; Pu W; Zhou C; Zhang R; Liu B; Pan Y; Zhang J; Li P; Lil K
    J Nanosci Nanotechnol; 2015 May; 15(5):3939-43. PubMed ID: 26505028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.
    Yoshida S; Hige S; Yoshida M; Yamashita N; Fujisawa S; Sato K; Kitamura T; Nishimura M; Chuma M; Asaka M; Chiba H
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):59-64. PubMed ID: 18275675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
    Lok AS; Zoulim F; Locarnini S; Mangia A; Niro G; Decraemer H; Maertens G; Hulstaert F; De Vreese K; Sablon E
    J Clin Microbiol; 2002 Oct; 40(10):3729-34. PubMed ID: 12354872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
    Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
    J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of hepatitis B virus quasispecies during antiviral therapy in one chronic hepatitis B patient].
    Liang PP; Guo JJ; Li QL; Luo Q; Shi XF; Huang AL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):516-20. PubMed ID: 22152243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
    Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine.
    Xu G; You Q; Pickerill S; Zhong H; Wang H; Shi J; Luo Y; You P; Kong H; Lu F; Hu L
    J Med Virol; 2010 Jul; 82(7):1143-9. PubMed ID: 20513076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
    Coppola N; Tonziello G; Colombatto P; Pisaturo M; Messina V; Moriconi F; Alessio L; Sagnelli C; Cavallone D; Brunetto M; Sagnelli E
    J Infect; 2013 Oct; 67(4):322-8. PubMed ID: 23796869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
    Kim JK; Lee HJ; Lee YJ; Chun JY; Lee IK; Lim YS; Suh DJ; Ko SY; Kim MH; Oh HB
    J Virol Methods; 2008 Apr; 149(1):76-84. PubMed ID: 18291537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
    León P; Pozo F; Echevarría JM
    Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):133-7. PubMed ID: 14987532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients.
    Umeoka F; Iwasaki Y; Matsumura M; Takaki A; Kobashi H; Tatsukawa M; Shiraha H; Fujioka S; Sakaguchi K; Shiratori Y
    J Gastroenterol; 2006 Jul; 41(7):693-701. PubMed ID: 16933008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
    Zhu Y; Curtis M; Borroto-Esoda K
    Antivir Chem Chemother; 2011 Aug; 22(1):13-22. PubMed ID: 21860069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication.
    Billioud G; Pichoud C; Puerstinger G; Neyts J; Zoulim F
    Antiviral Res; 2011 Nov; 92(2):271-6. PubMed ID: 21871497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
    Jang H; Kim J; Choi JJ; Son Y; Park H
    J Clin Microbiol; 2010 Sep; 48(9):3127-31. PubMed ID: 20573874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.